ellagic acid - CISMeF

Preferred Label : ellagic acid;

MeSH definition : A fused four ring compound occurring free or combined in galls. Isolated from the kino of Eucalyptus maculata Hook and E. Hemipholia F. Muell. Activates Factor XII of the blood clotting system which also causes kinin release; used in research and as a dye.;

MeSH synonym : acid, ellagic; benzoaric acid; acid, benzoaric;

MeSH CAS label : (1)Benzopyrano(5,4,3-cde)(1)benzopyran-5,10-dione, 2,3,7,8-tetrahydroxy-;

MeSH Related Number : 476-66-4 (Ellagic acid);

Registry Number MeSH : 476-66-4;

Wikipedia link : https://en.wikipedia.org/wiki/Ellagic acid;

Codes EINECS : 207-508-3;

Is substance : O;

UNII : 19YRN3ZS9P;

InChIKey : AFSDNFLWKVMVRB-UHFFFAOYSA-N;

Details

Origin ID

D004610;

UMLS CUI

C0013900;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- ellagic acid [Substance BNPC]
Currated CISMeF NLP mapping
- Ellagic Acid [NCIt concept]
Record concept(s)
- ellagic acid [MeSH concept]
Related MeSH Supplementary Concept(s)
- 2,2',3,3',4,4'-hexahydroxy-1,1'-biphenyl-6,6'-dimethanol dimethyl ether [MeSH Supplementary Concept]
- 2-(2,3,6-trihydroxy-4-carboxyphenyl) ellagic acid [MeSH Supplementary Concept]
- 3'-O-methyl-3,4-methylenedioxyellagic acid 4'-O-beta-d-glucopyranoside [MeSH Supplementary Concept]
- 3'-O-methylellagic acid [MeSH Supplementary Concept]
- 3,3',4'-tri-O-methylellagic acid 4-O-beta-glucupyranuronide [MeSH Supplementary Concept]
- 3,3',4-tri-O-methylellagic acid-4'-O-beta-D-xyloside [MeSH Supplementary Concept]
- 3,3'-O-methylellagic acid [MeSH Supplementary Concept]
- 3,3'-di-O-methylellagic acid [MeSH Supplementary Concept]
- 3,3'-di-O-methylellagic acid 4'-O-beta-D-xylopyranoside [MeSH Supplementary Concept]
- 3,3'-dimethoxy ellagic acid [MeSH Supplementary Concept]
- 3,4'-O-dimethylellagic acid 4-O-alpha-L-rhamnopyranoside [MeSH Supplementary Concept]
- 3,4,3'-trimethoxy flavellagic acid 4'-O-glucoside [MeSH Supplementary Concept]
- 3,4,3'-trimethoxyflavellagic acid [MeSH Supplementary Concept]
- 3,4,5,5'-O-tetramethyl-3',4'-O,O-methylidenecoruleoellagic acid d [MeSH Supplementary Concept]
- 3,4,5-O-trimethyl-3',4'-O,O-methylidineflavellagic acid [MeSH Supplementary Concept]
- 3,4-di-O-methylellagic acid [MeSH Supplementary Concept]
- 3,4:3',4'-bis(O,O-methylene)ellagic acid [MeSH Supplementary Concept]
- 3,7,8-tri-O-methylellagic acid [MeSH Supplementary Concept]
- 3,7,8-tri-O-methylellagic acid 4-glucoside [MeSH Supplementary Concept]
- 3-O-decylellagic acid [MeSH Supplementary Concept]
- 3-O-methyl-3',4'-methylenedioxyellagic acid [MeSH Supplementary Concept]
- 3-O-methylellagic acid 4'-O-alpha-L-2''-O-acetyl-rhamnopyranoside [MeSH Supplementary Concept]
- 3-O-methylellagic acid 4-O-alpha-L-rhamnopyranoside [MeSH Supplementary Concept]
- 3-methoxyellagic acid 4-O-beta-glucopyranoside [MeSH Supplementary Concept]
- 3-methoxyellagic acid 4-O-galactopyranoside [MeSH Supplementary Concept]
- 3-methoxyellagic acid 4-O-rhamnopyranoside [MeSH Supplementary Concept]
- 4'-O-methylellagic acid 4-O-beta-D-glucopyranoside [MeSH Supplementary Concept]
- 4,4'-O-methylellagic acid [MeSH Supplementary Concept]
- 4-(4''-O-acetyl-alpha-rhamnopyranosyl)ellagic acid [MeSH Supplementary Concept]
- 4-(alpha-rhamnopyranosyl)ellagic acid [MeSH Supplementary Concept]
- 4-O-(3'',4''-di-O-galloyl-a-L-rhamnopyrahosyl)ellagic acid [MeSH Supplementary Concept]
- 4-O-methylellagic acid [MeSH Supplementary Concept]
- 4-O-methylellagic acid 3'-(3''-O-acetyl)-alpha-rhamnoside [MeSH Supplementary Concept]
- 4-O-methylellagic acid 3'-(4''-O-acetyl)-alpha-rhamnoside [MeSH Supplementary Concept]
- 4-O-methylellagic acid 3'-alpha-rhamnoside [MeSH Supplementary Concept]
- desglauside [MeSH Supplementary Concept]
- diellagic acid rhamnosyl (1-4) glucopyranoside [MeSH Supplementary Concept]
- ducheside A [MeSH Supplementary Concept]
- ducheside B [MeSH Supplementary Concept]
- ellagic acid 3,3'-dimethylether [MeSH Supplementary Concept]
- ellagic acid 4-O-xylopyranoside [MeSH Supplementary Concept]
- ellagic acid peracetate [MeSH Supplementary Concept]
- ellagic acid-4-O-beta-D-glucopyranoside [MeSH Supplementary Concept]
- eschweilenol C [MeSH Supplementary Concept]
- flavellagic acid [MeSH Supplementary Concept]
- methoxyellagic acid sodium sulphate [MeSH Supplementary Concept]
- okicamelliaside [MeSH Supplementary Concept]
- runcinatside [MeSH Supplementary Concept]
- stachyanthuside A [MeSH Supplementary Concept]
- stachyanthuside B [MeSH Supplementary Concept]
Semantic type(s)
- Biologically Active Substance [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Ellagic Acid [NCIt concept]
- ellagic acid [Substance BNPC]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients